Abstract:Current pulmonary arterial hypertension (PAH) therapeutic strategies mainly focus on vascular relaxation with less emphasis on vascular remodeling, which results in poor prognosis. Hence, dual pathway regulators with vasodilation effect via soluble guanylate cyclase (sGC) stimulation and vascular remodeling regulation effect by AMP-activated protein kinase (AMPK) inhibition provide more advantages and potentialities. Herein, we designed and synthesized a series of novel pyrazolo[3,4-b] pyridine derivatives based on sGC stimulator and AMPK inhibitor scaffolds. In vitro, 2 exhibited moderate vasodilation activity and higher proliferation and migration suppressive effects compared to riociguat. In vivo, 2 significantly decreased right ventricular systolic pressure (RVSP), attenuated pulmonary artery medial thickness (PAMT), and right ventricular hypertrophy (RVH) in hypoxia-induced PAH rat models (i.g.). Given the unique advantages of significant vascular remodeling inhibition and moderate vascular relaxation based on the dual pathway regulation, we proposed 2 as a promising lead for anti-PAH drug discovery.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01132?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01132</a>.Molecular formula strings and biological data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01132/suppl_file/jm0c01132_si_001.csv">CSV</a>)1H NMR, 13C NMR, HRMS, and HPLC spectra of target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01132/suppl_file/jm0c01132_si_002.pdf">PDF</a>)This article has not yet been cited by other publications.

Discovery of Furyl/thienyl Β-Carboline Derivatives As Potent and Selective PDE5 Inhibitors with Excellent Vasorelaxant Effect.

Design and synthesis of furyl/thineyl pyrroloquinolones based on natural alkaloid perlolyrine, lead to the discovery of potent and selective PDE5 inhibitors.

Synthesis and Biological Evaluation of Novel Biphenyl-Furocoumarin Derivatives As Vasodilator Agents

Discovery and Optimization of Chromeno[2,3-c]pyrrol-9(2H)-ones As Novel Selective and Orally Bioavailable Phosphodiesterase 5 Inhibitors for the Treatment of Pulmonary Arterial Hypertension.

Optimization of Chromeno[2,3-c]pyrrol-9(2H)-ones as Highly Potent, Selective, and Orally Bioavailable PDE5 Inhibitors: Structure-Activity Relationship, X-ray Crystal Structure, and Pharmacodynamic Effect on Pulmonary Arterial Hypertension.

Design of Novel Thiazole Bearing Pyrazole Derivatives and Their Dual Activities as ACE Inhibitors and Calcium Channel Blockers in Cardiovascular Disease

Synthesis and bioactivity of phenyl substituted furan and oxazole carboxylic acid derivatives as potential PDE4 inhibitors

Design, synthesis, and pharmacological evaluation of monocyclic pyrimidinones as novel inhibitors of PDE5.

Discovery of 3-(4-hydroxybenzyl)-1-(thiophen-2-yl)chromeno[2,3-c]pyrrol-9(2h)-one As a Phosphodiesterase-5 Inhibitor and Its Complex Crystal Structure.

Discovery of Novel Purine Nucleoside Derivatives As Phosphodiesterase 2 (PDE2) Inhibitors: Structure-based Virtual Screening, Optimization and Biological Evaluation

Discovery and Optimization of Dihydroquinolin-2(1 H )-ones as Novel Highly Selective and Orally Bioavailable Phosphodiesterase 5 Inhibitors for the Treatment of Pulmonary Arterial Hypertension

Discovery of a novel series of α-terpineol derivatives as promising anti-asthmatic agents: Their design, synthesis, and biological evaluation.

Synthesis and Vasorelaxation Evaluation of Novel Biphenyl–furocoumarin Derivatives

Design, Synthesis and Evaluation of 9-Hydroxy-7h-furo[3,2-g]chromen-7-one Derivatives As New Potential Vasodilatory Agents

Synthesis and Biological Evaluation of Vinpocetine Derivatives

Design, Synthesis, and Biological Evaluation of Benzofuran Derivatives As ET Receptor Antagonists

Synthesis and bioactivity of pyrazole and triazole derivatives as potential PDE4 inhibitors.

Discovery of Novel Pyrazolo[3,4- b ] Pyridine Derivatives with Dual Activities of Vascular Remodeling Inhibition and Vasodilation for the Treatment of Pulmonary Arterial Hypertension

Discovery of highly selective and orally available benzimidazole-based phosphodiesterase 10 inhibitors with improved solubility and pharmacokinetic properties for treatment of pulmonary arterial hypertension

Discovery and Optimization of Chromone Derivatives as Novel Selective Phosphodiesterase 10 Inhibitors.

Synthesis of 4-Amino-5-furyl-2-yl-4h-1, 2, 4-Triazole-3-thiol Derivatives As a Novel Class of Endothelin（ET） Receptor Antagonists